摘要

Authors' objectives: This health technology assessment evaluates the effectiveness and safety of 5-aminolevulinic acid hydrochloride (5 ALA)–guided surgical resection of high-grade gliomas in adults. It also evaluates the budget impact of publicly funding 5 ALA and the experiences, preferences, and values of a person with high-grade glioma.